Activity of glycylcyclines CL 329998 and CL 331002 against minocycline-resistant and other strains of methicillin-resistant Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 6, 1996, Pages 1171-1175

  Hamilton Miller, J M T ^a   Shah, Saroj ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 DEOXY 7 DIMETHYLAMINO 9 (N,N DIMETHYLGLYCINAMIDO) 6 NORTETRACYCLINE; ANTIBIOTIC AGENT; CL 331002; MINOCYCLINE; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STRAIN DIFFERENCE;

EID: 0029737275     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.6.1171     Document Type: Article

References (12)

1. Archer, G. L. & Climo, M. W. (1994). Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrobial Agents and Chemotherapy 38, 2231-7.
2. Eliopolous, G. M., Wennersten, C. B., Cole, G. & Moellering, R. C. (1994). In vitro activities of two glycylcyclines against gram-positive bacteria. Antimicrobial Agents and Chemotherapy 38, 534-41.
3. Freeman, C. D., Nightingale, C. H. & Quintiliani, R. (1994). Minocycline: old and new therapeutic uses. International Journal of Antimicrobial Agents 4, 325-35.
4. Goldstein, F. W., Kitzis, M. D. & Acar, J. F. (1994). N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci. Antimicrobial Agents and Chemotherapy 38, 2218-20.
5. Maple, P. A. C., Hamilton-Miller, J. M. T. & Brumfitt, W. (1989). World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet i, 537-40.
6. National Committee for Clinical Laboratory Standards (1993). Performance Standards for Antimicrobial Disk Susceptibility Tests - Fifth Edition; Approved Standard. Document M2-A5. NCCLS. Villanova, PA.
7. Oxoid. (1980). Error Minimization in Susceptibility Testing by Means of the Agar Diffusion Test. Oxoid Ltd. Basingstoke, UK.
8. Soussy, C. J., Cluzel, R., Courvalin, P. and the Comite de l'Antibiogramme de la Societe Francaise be Microbiologie. (1994). Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria in France. European Journal of Clinical Microbiology and Infectious Diseases 13, 238-46.
9. Speer, B. S., Shoemaker, N. B. & Salyers, A. A. (1992). Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance. Clinical Microbiology Reviews 5, 387-99.
10. Testa, R. T., Petersen, P. J., Jacobus, N. V., Sum, F.-E., Lee, V. J. & Tally, F. P. (1993). In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines. Antimicrobial Agents and Chemotherapy 37, 2270-7.
11. Weiss, W. J., Jacobus, N. V., Petersen, P. J. & Testa, R. T. (1995). Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines. Journal of Antimicrobial Chemotherapy 36, 225-30.
12. Working Party of the British Society for Antimicrobial Chemotherapy. (1991). A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy 27, Suppl. D.